Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans.

Berardelli R, Margarito E, Ghiggia F, Picu A, Balbo M, Bonelli L, Giordano R, Karamouzis I, Bo M, Ghigo E, Arvat E.

J Endocrinol Invest. 2010 Oct;33(9):657-62. doi: 10.3275/6994. Epub 2010 Apr 22.

2.

Neuroendocrine effects of citalopram infusion in anorexia nervosa.

Mondelli V, Gianotti L, Picu A, Abbate Daga G, Giordano R, Berardelli R, Pariante CM, Fassino S, Ghigo E, Arvat E.

Psychoneuroendocrinology. 2006 Nov;31(10):1139-48. Epub 2006 Oct 11.

PMID:
17045409
3.

Effects of oral racemic citalopram on neuroendocrine responses.

Hawken ER, Owen JA, Van Vugt D, Delva NJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jun;30(4):694-700. Epub 2006 Mar 6.

PMID:
16563590
4.

Low-dose citalopram as a 5-HT neuroendocrine probe.

Attenburrow MJ, Mitter PR, Whale R, Terao T, Cowen PJ.

Psychopharmacology (Berl). 2001 May;155(3):323-6.

PMID:
11432696
5.

Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade.

Giordano R, Bo M, Pellegrino M, Vezzari M, Baldi M, Picu A, Balbo M, Bonelli L, Migliaretti G, Ghigo E, Arvat E.

J Clin Endocrinol Metab. 2005 Oct;90(10):5656-62. Epub 2005 Jul 12.

PMID:
16014406
6.

Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.

Arvat E, Maccagno B, Giordano R, Pellegrino M, Broglio F, Gianotti L, Maccario M, Camanni F, Ghigo E.

J Clin Endocrinol Metab. 2001 Jul;86(7):3176-81.

PMID:
11443185
7.

Oral application of citalopram (20 mg) and its usefulness for neuroendocrine challenge tests.

Henning J, Netter P.

Int J Neuropsychopharmacol. 2002 Mar;5(1):67-71.

PMID:
14609009
8.

The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls.

Kilkens TO, Honig A, Fekkes D, Brummer RJ.

Aliment Pharmacol Ther. 2005 Nov 1;22(9):865-74.

9.

Effect of sleep deprivation on neuroendocrine response to a serotonergic probe in healthy male subjects.

Seifritz E, Müller MJ, Annen O, Nil R, Hatzinger M, Hemmeter U, Moore P, Holsboer-Trachsler E.

J Psychiatr Res. 1997 Sep-Oct;31(5):543-54.

PMID:
9368196
10.

A study of central serotoninergic activity in healthy subjects and patients with Type 2 diabetes treated by traditional one-to-one care or Group Care.

Trento M, Kucich C, Tibaldi P, Gennari S, Tedesco S, Balbo M, Arvat E, Cavallo F, Ghigo E, Porta M.

J Endocrinol Invest. 2010 Oct;33(9):624-8. doi: 10.3275/6815. Epub 2010 Feb 5.

PMID:
20142635
11.

Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.

Nadeem HS, Attenburrow MJ, Cowen PJ.

Neuropsychopharmacology. 2004 Sep;29(9):1699-703.

12.
13.

Desmopressin and low-dose ACTH test in rheumatoid arthritis.

Foppiani L, Cutolo M, Sessarego P, Sulli A, Prete C, Seriolo B, Giusti M.

Eur J Endocrinol. 1998 Mar;138(3):294-301.

PMID:
9539304
14.

Estradiol, but not testosterone, heightens cortisol-mediated negative feedback on pulsatile ACTH secretion and ACTH approximate entropy in unstressed older men and women.

Sharma AN, Aoun P, Wigham JR, Weist SM, Veldhuis JD.

Am J Physiol Regul Integr Comp Physiol. 2014 May;306(9):R627-35. doi: 10.1152/ajpregu.00551.2013. Epub 2014 Feb 26.

15.

Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans.

Gianotti L, Ramunni J, Lanfranco F, Maccagno B, Giordano R, Broglio F, Maccario M, Muller EE, Ghigo E, Arvat E.

J Endocrinol Invest. 2001 Feb;24(2):67-71.

PMID:
11263473
16.

Elderly subjects show severe impairment of dehydroepiandrosterone sulphate and reduced sensitivity of cortisol and aldosterone response to the stimulatory effect of ACTH(1-24).

Giordano R, Di Vito L, Lanfranco F, Broglio F, Benso A, Gianotti L, Grottoli S, Ghigo E, Arvat E.

Clin Endocrinol (Oxf). 2001 Aug;55(2):259-65.

PMID:
11531935
17.

The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations.

Arvat E, Ramunni J, Bellone J, Di Vito L, Baffoni C, Broglio F, Deghenghi R, Bartolotta E, Ghigo E.

Eur J Endocrinol. 1997 Dec;137(6):635-42.

PMID:
9437229
18.

Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences.

Lotrich FE, Bies R, Muldoon MF, Manuck SB, Smith GS, Pollock BG.

Psychopharmacology (Berl). 2005 Mar;178(2-3):268-75. Epub 2004 Sep 9.

PMID:
15365685
19.

Effect of acute corticotropin releasing factor on pituitary-adrenocortical responsiveness in elderly women and men.

Luisi S, Tonetti A, Bernardi F, Casarosa E, Florio P, Monteleone P, Gemignani R, Petraglia F, Luisi M, Genazzani AR.

J Endocrinol Invest. 1998 Jul-Aug;21(7):449-53.

PMID:
9766260
20.

Hormone responses to citalopram in abstinent alcohol dependent subjects.

Gotjen D, Szabo Z, Lee S, Wand G.

Alcohol Clin Exp Res. 2002 Nov;26(11):1625-31.

PMID:
12436050

Supplemental Content

Support Center